Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (21-30 of 715) with videos related to

Pageof 72
Sort By:
Schweizerische Medizinische Wochenschrift|November 14, 1987
Fibrin-specific thrombolytic agentsD Collen
Seminars in Thrombosis and Hemostasis|January 1, 1988
Potential approaches for therapeutic intervention of thrombosis by fibrinolytic agentsD Collen
Journal of the American College of Cardiology|November 1, 1987
Molecular mechanism of action of newer thrombolytic agentsD Collen
Circulation|March 1, 1996
Fibrin-selective thrombolytic therapy for acute myocardial infarctionD Collen
Lancet (London, England)|May 12, 1979
alpha2-Antiplasmin inhibitor deficiencyD Collen
Lancet (London, England)|July 3, 1993
Towards improved thrombolytic therapyD Collen
Bibliotheca Haematologica|January 1, 1983
Treatment of disseminated intravascular coagulationD Collen
Scandinavian Journal of Haematology. Supplementum|January 1, 1971
Hydrostatic pressure and reversible polymerization of fibrin monomersD Collen
The American Journal of Cardiology|January 3, 1992
Designing thrombolytic agents: focus on safety and efficacyD Collen
Thrombosis Research|December 1, 1974
Emergence in plasma during activation of the coagulation or fibrinolytic systems of neoantigens, associated with the complexes of thrombin or plasmin with their inhibitorsD Collen
Pageof 72

Showing results (21-30 of 715) with videos related to

Sort By:
Pageof 72
Schweizerische Medizinische Wochenschrift|November 14, 1987
Fibrin-specific thrombolytic agentsD Collen
Seminars in Thrombosis and Hemostasis|January 1, 1988
Potential approaches for therapeutic intervention of thrombosis by fibrinolytic agentsD Collen
Journal of the American College of Cardiology|November 1, 1987
Molecular mechanism of action of newer thrombolytic agentsD Collen
Circulation|March 1, 1996
Fibrin-selective thrombolytic therapy for acute myocardial infarctionD Collen
Lancet (London, England)|May 12, 1979
alpha2-Antiplasmin inhibitor deficiencyD Collen
Lancet (London, England)|July 3, 1993
Towards improved thrombolytic therapyD Collen
Bibliotheca Haematologica|January 1, 1983
Treatment of disseminated intravascular coagulationD Collen
Scandinavian Journal of Haematology. Supplementum|January 1, 1971
Hydrostatic pressure and reversible polymerization of fibrin monomersD Collen
The American Journal of Cardiology|January 3, 1992
Designing thrombolytic agents: focus on safety and efficacyD Collen
Thrombosis Research|December 1, 1974
Emergence in plasma during activation of the coagulation or fibrinolytic systems of neoantigens, associated with the complexes of thrombin or plasmin with their inhibitorsD Collen
Pageof 72